KR950702122A - 기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract) - Google Patents

기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract)

Info

Publication number
KR950702122A
KR950702122A KR1019940704706A KR19940704706A KR950702122A KR 950702122 A KR950702122 A KR 950702122A KR 1019940704706 A KR1019940704706 A KR 1019940704706A KR 19940704706 A KR19940704706 A KR 19940704706A KR 950702122 A KR950702122 A KR 950702122A
Authority
KR
South Korea
Prior art keywords
remedy
prophylactic
respiratory tract
viral diseases
viral
Prior art date
Application number
KR1019940704706A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950702122A publication Critical patent/KR950702122A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019940704706A 1992-06-24 1994-12-23 기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract) KR950702122A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16587592A JP3961029B2 (ja) 1992-06-24 1992-06-24 インフルエンザウィルス感染防止剤
PCT/JP1993/000851 WO1994000131A1 (en) 1992-06-24 1993-06-23 Prophylactic and remedy for viral diseases in respiratory tract

Publications (1)

Publication Number Publication Date
KR950702122A true KR950702122A (ko) 1995-06-19

Family

ID=15820643

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704706A KR950702122A (ko) 1992-06-24 1994-12-23 기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract)

Country Status (6)

Country Link
EP (1) EP0652011A4 (ko)
JP (1) JP3961029B2 (ko)
KR (1) KR950702122A (ko)
AU (1) AU690520B2 (ko)
CA (1) CA2138281A1 (ko)
WO (1) WO1994000131A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015199456A1 (ko) * 2014-06-25 2015-12-30 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970701561A (ko) * 1994-03-23 1997-04-12 아사이 이뻬이 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)
WO1996017872A1 (fr) * 1994-12-07 1996-06-13 Tokyo Tanabe Company Limited Intermediaire pour la production d'un peptide surfactant
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
DK1173194T3 (da) 1999-01-19 2004-10-18 Altana Pharma Ag Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
KR20030033266A (ko) * 2001-10-19 2003-05-01 (주)인터루션 사용자의 영상정보 분석을 통한 사이버 비서 시스템 및 그방법
GB0201028D0 (en) * 2002-01-17 2002-03-06 Britannia Pharmaceuticals Ltd Prevention of infectious diseases
EP1531795A4 (en) * 2002-05-02 2011-02-23 Harvard College FORMULATIONS LIMITING THE EXTENSION OF PULMONARY INFECTIONS
EP1711163A2 (en) * 2004-02-05 2006-10-18 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
JP4843792B2 (ja) * 2004-04-05 2011-12-21 国立大学法人徳島大学 経粘膜及び経皮投与を可能にする抗原薬物ヴィークル、これを用いる粘膜免疫の誘導方法、粘膜ワクチン及びｄｄｓ
WO2007018152A1 (ja) * 2005-08-05 2007-02-15 The University Of Tokushima IgA抗体の選択的産生からIgA及びIgG両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン
WO2008121811A2 (en) * 2007-03-29 2008-10-09 National Jewish Medical And Research Center Surfactant lipids, compositions thereof, and uses thereof
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US9061352B2 (en) 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012044736A1 (en) 2010-09-29 2012-04-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
NZ629722A (en) 2012-02-29 2017-03-31 Pulmatrix Operating Co Inc Inhalable dry powders
JP6473738B2 (ja) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド チオトロピウム乾燥粉末
WO2023281523A1 (en) * 2021-07-09 2023-01-12 Indian Council Of Medical Research A pharmaceutical composition with a recombinant fragment of human surfactant protein-d for sars-cov-2 infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58183620A (ja) * 1982-04-22 1983-10-26 Teijin Ltd 肺表面活性物質及びその製造方法
JPS58222022A (ja) * 1982-06-21 1983-12-23 Teijin Ltd 合成肺表面活性剤及びそれを有効成分とする呼吸窮迫症候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
JPS6034905A (ja) * 1983-08-05 1985-02-22 Tokyo Tanabe Co Ltd 肺表面活性物質製剤
JPS6429319A (en) * 1987-07-23 1989-01-31 Toyama Chemical Co Ltd Antiviral agent containing lysolecithin and phospholipid
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3929217A1 (de) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
EP0528034B1 (en) * 1990-05-18 1999-04-21 Tokyo Tanabe Company Limited Remedy for asthma

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015199456A1 (ko) * 2014-06-25 2015-12-30 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물
KR20160000751A (ko) * 2014-06-25 2016-01-05 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물
US10092587B2 (en) 2014-06-25 2018-10-09 Korea Research Institute Of Bioscience And Biotechnology Antiviral composition containing material involved in phosphatidylcholine synthesis pathway

Also Published As

Publication number Publication date
CA2138281A1 (en) 1994-01-06
JP3961029B2 (ja) 2007-08-15
JPH069428A (ja) 1994-01-18
EP0652011A4 (en) 1996-06-05
WO1994000131A1 (en) 1994-01-06
AU690520B2 (en) 1998-04-30
AU4357393A (en) 1994-01-24
EP0652011A1 (en) 1995-05-10

Similar Documents

Publication Publication Date Title
KR950702122A (ko) 기도부 바이러스 질환의 예방 및 치료제(Prophylactic and Remedy for Viral Diseases in Respiratory Tract)
DK479189D0 (da) Inhalator
NO921110D0 (no) Inhalator
ATA43791A (de) Inhaliergerät und medikamentenpackung hierfür
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
EP0818976A4 (en) DISPOSABLE MASK AND SUCTION CATHETER
EP0711572A4 (en) INHALATOR AND METHOD FOR USE THEREOF
NO952672D0 (no) Pustemaske
DE69122118D1 (de) Inhaliergerät
EP0769974A4 (en) IMPROVED INHALER AND PACKAGING FOR MEDICINES
AU5037593A (en) Vaccines inducing an immune response against viruses causing porcine respiratory and reproductive diseases
FI951367A (fi) Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
IS4263A (is) Innúðatæki
DE69003923D1 (de) Inhalator und Schutzbehälter.
GB9722393D0 (en) Laryneeal mask airways and their manufacture
PT983271E (pt) Hemissulfato carbociclico nucleosidico e a sua utilizacao no tratamento de infeccoes virais
AU2097900A (en) Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof
PL316444A1 (en) Novel agent against viral diseases of respiratory tracts
HU913022D0 (en) Fibroplast increasing factor for treating and preventing virus caused diseases
KR970020904U (ko) 어린이용 방독면
PL284057A1 (en) Oral and nasal inhaler
KR960004083U (ko) 콧구멍용 마스크
SE9003230L (sv) Andningsmask
KR930025079U (ko) 기도관 고정 및 구강내 이물질 제거용 마우스피스
NO932380D0 (no) Inhalator

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application